Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes

✍ Scribed by Alasdair J Coles; Edward Fox; Anton Vladic; Suzanne K Gazda; Vesna Brinar; Krzysztof W Selmaj; Ann Doan-Do Bass; Daniel R Wynn; David H Margolin; Stephen L Lake; Susan Moran; Jeffrey Palmer; M Shelton Smith; D Alastair S Compston

• Book ID: 114409732
• Publisher: The Lancet
• Year: 2011
• Tongue: English
• Weight: 306 KB
• Volume: 10
• Category: Article
• ISSN: 1474-4465
• DOI: 10.1016/s1474-4422(11)70020-5